The G-712A polymorphism of brain-derived neurotrophic factor is associated with major depression but not schizophrenia

Neuroscience Letters

Volumn 489, Issue 1, 2011, Pages 34-37

  Sun, R F ^a,b   Zhu, Y S ^a,d   Kuang, W J ^a,b   Liu, Y ^a,c   Li, S B ^a,c  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c INSTITUTE OF FORENSIC SCIENCE   (China)

^d Key Laboratory of Reproduction and Genetics of Ningxia Hui Autonomous Region   (China)

Author keywords

Brain derived neurotrophic factor; Major depression; Polymorphism; Schizophrenia

Indexed keywords

ADENINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOSINE; GUANINE; METHIONINE; THYMINE; VALINE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HAMILTON SCALE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SCHIZOPHRENIA;

BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

EID: 78650842375     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.11.061     Document Type: Article

References (43)

1. Altar C.A., Whitehead R.E., Chen R., Wortwein G., Madsen T.M. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol. Psychiatry 2003, 54:703-709.
2. Ashe P.C., Berry M.D., Boulton A.A. Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents. Prog. Neuropsychopharmacol. Biol. Psychiatry 2001, 25:691-707.
3. A.P. Association, Diagnostic and Statistical Manual of Mental Disorders, Text Revision, 4th ed., American Psychiatric Association Press, Washington, DC, 2000.
4. Bai O., Chlan-Fourney J., Bowen R., Keegan D., Li X.M. Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. J. Neurosci. Res. 2003, 71:127-131.
5. Castren E. Neurotrophic effects of antidepressant drugs. Curr. Opin. Pharmacol. 2004, 4:58-64.
6. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 2001, 50:260-265.
7. Duman R.S., Vaidya V.A. Molecular and cellular actions of chronic electroconvulsive seizures. J. ECT 1998, 14:181-193.
8. Durany N., Michel T., Zochling R., Boissl K.W., Cruz-Sanchez F.F., Riederer P., Thome J. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses. Schizophr. Res. 2001, 52:79-86.
9. Dwivedi Y., Rizavi H.S., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch. Gen. Psychiatry 2003, 60:804-815.
10. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
11. Frodl T., Schule C., Schmitt G., Born C., Baghai T., Zill P., Bottlender R., Rupprecht R., Bondy B., Reiser M., Moller H.J., Meisenzahl E.M. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch. Gen. Psychiatry 2007, 64:410-416.
12. Galderisi S., Maj M., Kirkpatrick B., Piccardi P., Mucci A., Invernizzi G., Rossi A., Pini S., Vita A., Cassano P., Stratta P., Severino G., Del Zompo M., Val(158)Met C.O.M.T. BDNF C(270)T polymorphisms in schizophrenia: a case-control study. Schizophr. Res. 2005, 73:27-30.
13. Grunblatt E., Hupp E., Bambula M., Zehetmayer S., Jungwirth S., Tragl K.H., Fischer P., Riederer P. Association study of BDNF and CNTF polymorphism to depression in non-demented subjects of the " VITA" study. J. Affect Disord. 2006, 96:111-116.
14. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967, 6:278-296.
15. Hashimoto T., Bergen S.E., Nguyen Q.L., Xu B., Monteggia L.M., Pierri J.N., Sun Z., Sampson A.R., Lewis D.A. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J. Neurosci. 2005, 25:372-383.
16. Hong C.J., Huo S.J., Yen F.C., Tung C.L., Pan G.M., Tsai S.J. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 2003, 48:186-189.
17. Hong C.J, Yu Y.W., Lin C.H., Tsai S.J. An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci. Lett. 2003, 349:206-208.
18. Hwang J.P., Tsai S.J., Hong C.J., Yang C.H., Lirng J.F., Yang Y.M. The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol. Aging 2006, 27:1834-1837.
19. Jockers-Scherubl M.C., Danker-Hopfe H., Mahlberg R., Selig F., Rentzsch J., Schurer F., Lang U.E., Hellweg R. Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse. Neurosci. Lett. 2004, 371:79-83.
20. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., Aubry J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002, 109:143-148.
21. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 1994, 51:8-19.
22. Levinson D.F. The genetics of depression: a review. Biol. Psychiatry 2006, 60:84-92.
23. Nanko S., Kunugi H., Hirasawa H., Kato N., Nabika T., Kobayashi S. Brain-derived neurotrophic factor gene and schizophrenia: polymorphism screening and association analysis. Schizophr. Res. 2003, 62:281-283.
24. Neves-Pereira M., Cheung J.K., Pasdar A., Zhang F., Breen G., Yates P., Sinclair M., Crombie C., Walker N., St Clair D.M. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol. Psychiatry 2005, 10:208-212.
25. Pirildar S., Gonul A.S., Taneli F., Akdeniz F. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28:709-713.
26. Ribeiro L., Busnello J.V., Cantor R.M., Whelan F., Whittaker P., Deloukas P., Wong M.L., Licinio J. The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans. Neuroreport 2007, 18:1291-1293.
27. Rosa A., Cuesta M.J., Fatjo-Vilas M., Peralta V., Zarzuela A., Fananas L. The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study. Am. J. Med. Genet. B Neuropsychiatry Genet. 2006, 141B:135-138.
28. Sakata K., Jin L., Jha S. Lack of promoter IV-driven BDNF transcription results in depression-like behavior. Genes Brain Behav. 2010, 9:712-721.
29. Schumacher J., Jamra R.A., Becker T., Ohlraun S., Klopp N., Binder E.B., Schulze T.G., Deschner M., Schmal C., Hofels S., Zobel A., Illig T., Propping P., Holsboer F., Rietschel M., Nothen M.M., Cichon S. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry 2005, 58:307-314.
30. Seretti A., Cusin C., Lattuada E., Di Bella D., Catalano M., Smeraldi E. Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders. Mol. Psychiatry 1999, 4:280-283.
31. Shimizu E., Hashimoto K., Iyo M. Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am. J. Med. Genet. B Neuropsychiatry Genet. 2004, 126B:122-123.
32. Shimizu E., Hashimoto K., Watanabe H., Komatsu N., Okamura N., Koike K., Shinoda N., Nakazato M., Kumakiri C., Okada S., Iyo M. Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neurosci. Lett. 2003, 351:111-114.
33. Szczepankiewicz A., Skibinska M., Czerski P.M., Kapelski P., Leszczynska-Rodziewicz A., Slopien A., Dmitrzak-Weglarz M., Rybakowski F., Rybakowski J., Hauser J. No association of the brain-derived neurotrophic factor (BDNF) gene C-270T polymorphism with schizophrenia. Schizophr. Res. 2005, 76:187-193.
34. Szekeres G., Juhasz A., Rimanoczy A., Keri S., Janka Z. The C270T polymorphism of the brain-derived neurotrophic factor gene is associated with schizophrenia. Schizophr. Res. 2003, 65:15-18.
35. Takahashi M., Shirakawa O., Toyooka K., Kitamura N., Hashimoto T., Maeda K., Koizumi S., Wakabayashi K., Takahashi H., Someya T., Nawa H. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol. Psychiatry 2000, 5:293-300.
36. Tang J., Xiao L., Shu C., Wang G., Liu Z., Wang X., Wang H., Bai X. Association of the brain-derived neurotrophic factor gene and bipolar disorder with early age of onset in mainland China. Neurosci. Lett. 2008, 433:98-102.
37. Thomas D.C., Witte J.S. Point: population stratification: a problem for case-control studies of candidate-gene associations?. Cancer Epidemiol. Biomarkers Prev. 2002, 11:505-512.
38. Toyooka K., Asama K., Watanabe Y., Muratake T., Takahashi M., Someya T., Nawa H. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res. 2002, 110:249-257.
39. Tsai S.J., Cheng C.Y., Yu Y.W., Chen T.J., Hong C.J. Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am. J. Med. Genet. B Neuropsychiatry Genet. 2003, 123B:19-22.
40. Weickert C.S, Hyde T.M., Lipska B.K., Herman M.M., Weinberger D.R., Kleinman J.E. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol. Psychiatry 2003, 8:592-610.
41. Xu M.Q., St Clair D., Ott J., Feng G.Y., He L. Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis. Schizophr. Res. 2007, 91:6-13.
42. Yamada K., Mizuno M., Nabeshima T. Role for brain-derived neurotrophic factor in learning and memory. Life Sci. 2002, 70:735-744.
43. Zhang H., Ozbay F., Lappalainen J., Kranzler H.R., van Dyck C.H., Charney D.S., Price L.H., Southwick S., Yang B.Z., Rasmussen A., Gelernter J. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am. J. Med. Genet. B Neuropsychiatry Genet. 2006, 141B:387-393.